Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma

Background Plasma Epstein–Barr virus (pEBV) DNA and fluorodeoxyglucose positron emission (PET) reflect tumour burden in advanced NPC. This study hypothesised that a dual endpoint based on assessing pEBV DNA clearance and PET response could predict early drug response. Methods Eligible patients under...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2018-04, Vol.118 (8), p.1051-1055
Hauptverfasser:	Ma, Brigette, Hui, Edwin P, King, Ann, Leung, Sing F, Kam, Michael KM, Mo, Frankie, Li, Leung, Wang, Ki, Loong, Herbert, Wong, Ashley, Chan, Charles ML, Chan, KC Allen, Wong, SC Cesar, Lo, YM Dennis, Chan, Anthony TC
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1536 692/4028/67/1536 Biomedical and Life Sciences Biomedicine Cancer Research Chemotherapy Computed tomography Deoxyribonucleic acid DNA Drug Resistance Emission analysis Epidemiology Epstein-Barr virus Evaluation Lesions Molecular Medicine Nasopharyngeal carcinoma Oncology Solid tumors Survival Throat cancer Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!